Lasaâd Boujbel, CEO of MédiS Group, and founder of the company, today leads what became one of the first Tunisian-based multinationals. His company’s recent investments in the Tunisian headquarters and in Senegal respectively respond to increased international demand and desires of expansion in the African market. MédiS has built up a portfolio encompassing 700 marketing authorizations for more than 250 products in 22 years and still has the ambition to grow further with a recent series of extensions in facilities.
MédiS is considered as the Tunisian multinational by excellence in the pharmaceutical industry. How did it all start?
"We are looking forward to reinforcing our portfolio of products with innovative molecules in promising therapeutic areas or niche markets."
